Jonathan Lee

Jonathan Lee

Auto-generated profile, based on publicly available information

Jonathan Lee

Department of Neurological Surgery, Loyola University Stritch School of Medicine, Maywood, Illinois, USA

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
15 December 2022 in World Neurosurgery
Verified
Journal Article
Closed access
IJIgnacio Jusue-Torres
Ignacio Jusue-Torres
JLJonathan Lee
Jonathan Lee
AGAnand V. Germanwala
Anand V. Germanwala
TBTerry C. Burns
Terry C. Burns
IPIan F. Parney
Ian F. Parney

25 January 2021 in Journal of the Endocrine Society
Verified
Journal Article
Open access
PDF file
JLJonathan Lee
Jonathan Lee
LALindsey Anderson
Lindsey Anderson
DMDorota Migula
Dorota Migula
KYKevin Choong Ji Yuen
Kevin Choong Ji Yuen
LMLisa McPeak
Lisa McPeak
JGJose Garcia
Jose Garcia
Context: Traumatic brain injury (TBI) is considered the “signature” injury of veterans returning from wartime conflicts in Iraq and Afghanistan. While moderate/severe TBI is associated with pituitary dysfunction, this association has not been well established in the military setting and in mild TBI (mTBI). Screening for pituitary dysfunction resulting from TBI in veteran populations is inconsistent across Veterans Affairs (VA) institutions, and such dysfunction often goes unrecognized and untreated. Objective: This work aims to report the experience of a pituitary clinic in screening for and diagnosis of pituitary dysfunction. Methods: A retrospective analysis was conducted in a US tertiary care center of veterans referred to the VA Puget Sound Healthcare System pituitary clinic with a history of TBI at least 12 months prior. Main outcome measures included demographics, medical history, symptom burden, baseline hormonal evaluation, brain imaging, and provocative testing for adrenal insufficiency (AI) and adult-onset growth hormone deficiency (AGHD). Results: Fatigue, cognitive/memory problems, insomnia, and posttraumatic stress disorder were reported in at least two-thirds of the 58 patients evaluated. Twenty-two (37.9%) were diagnosed with at least one pituitary hormone deficiency, including 13 (22.4%) AI, 12 (20.7%) AGHD, 2 (3.4%) secondary hypogonadism, and 5 (8.6%) hyperprolactinemia diagnoses; there were no cases of thyrotropin deficiency. Conclusion: A high prevalence of chronic AI and AGHD was observed among veterans with TBI. Prospective, larger studies are needed to confirm these results and determine the effects of hormone replacement on long-term outcomes in this setting.

6 July 2012 in Nephron Extra
Verified
Journal Article
Open access
EFElizabeth R. Flynn
Elizabeth R. Flynn
DMDavid C. Marbury
David C. Marbury
RSRoy T. Sawyer
Roy T. Sawyer
JLJonathan Lee
Jonathan Lee
CTChristine Teutsch
Christine Teutsch
CMChristine Maric-Bilkan
Christine Maric-Bilkan
Amlodipine reduces blood pressure; however, its effect in the diabetic kidney irrespective of its blood pressure-lowering effects is unclear. This study examined the effects of amlodipine (0, 5, 10 and 20 mg/kg; DA0, DA5, DA10 and DA20, respectively) for 12 weeks on renal functional and structural changes in the streptozotocin-induced diabetic rat, a nonhypertensive model of diabetes-associated hyperfiltration. Compared with nondiabetic rats, diabetes (D) was associated with increased urine albumin excretion (UAE, 12.6 ± 3.40 vs. 3.73 ± 1.14 mg/day), glomerular filtration rate (2.17 ± 0.09 vs. 1.64 ± 0.12 ml/min/g kidney weight), glomerulosclerosis (0.21 ± 0.03 vs. 0.05 ± 0.01 AU) and infiltration of inflammatory cells (18.5 ± 2.78 vs. 6.92 ± 0.70 cells/cm2), but did not affect mean arterial pressure (MAP, 110 ± 4.70 vs. 109 ± 5.33 mm Hg). While DA20 abolished glomerular hyperfiltration (1.49 ± 0.05 ml/min/g kidney weight) and inflammatory cell abundance (6.0 ± 0.79 cells/cm2), it exacerbated UAE (43.5 ± 8.49 mg/day) and increased MAP (132 ± 3.76 mm Hg), but had no effect on renal pathology. These data suggest that amlodipine reduces renal inflammation and abolished glomerular hyperfiltration, but increases blood pressure and exacerbates albuminuria in the rat model of normotensive diabetic kidney disease. We conclude that amlodipine may have limited renoprotective effects in the face of hyperfiltration and absence of elevated blood pressure.

1 December 2014 in JAMA Internal Medicine
Verified
Journal Article
Closed access
PDF file
JLJonathan S. Lee
Jonathan S. Lee
MFMichael J. Fine
Michael J. Fine
Opinion from JAMA Internal Medicine — The Debate on Antibiotic Therapy for Patients Hospitalized for Pneumonia — Where Should We Go From Here?